Wróć

Wybierz swój region

Corporate

Europa:

Flaga Albania Albania Flaga Bośnia i Hercegowina Bośnia i Hercegowina Flaga Bułgaria Bułgaria Flaga Chorwacja Chorwacja Flaga Cypr Cypr Flaga Czarnogóra Czarnogóra Flaga Czechy Czechy Flaga Dania Dania Flaga Estonia Estonia Flaga Hiszpania Hiszpania Flaga Kosowo Kosowo Flaga Litwa Litwa Flaga Łotwa Łotwa Flaga Luksemburg Luksemburg Flaga Macedonia Macedonia Flaga Niemcy Niemcy Flaga Polska Polska Flaga Portugalia Portugalia Flaga Rumunia Rumunia Flaga Serbia Serbia Flaga Słowacja Słowacja Flaga Słowenia Słowenia Flaga Szwajcaria Szwajcaria Flaga Szwecja Szwecja Flaga Turcja Turcja Flaga Węgry Węgry Flaga Wielka Brytania Wielka Brytania Flaga Włochy Włochy

Azja:

Flaga UAE UAE Flaga Hong Kong Hong Kong Flaga Kuwejt Kuwejt Flaga Liban Liban

Afryka:

Flaga RPA RPA

Umów konsultację o krwi pępowinowej

Umawiam

Skontaktuj się z nami już dziś!

Chcesz dowiedzieć się więcej o naszych usługach? Uzupełnij poniższy formularz, a my skontaktujemy się z Tobą jak najszybciej, aby udzielić Ci wszelkich potrzebnych informacji oraz odpowiedzieć na Twoje pytania.

    Uprzejmie informujemy, że dane osobowe podane w formularzu będą przetwarzane przez Polski Bank Komórek Macierzystych Sp. z o.o. („PBKM”) z siedzibą w Warszawie, Al. Jana Pawła II 29 w celu kontaktu telefonicznego w związku z udzieleniem informacji na temat usługi.

    Zestawienie leczonych pacjentów

    Terapie
    komórkami macierzystymi

    Terapie komórkami macierzystymi

    Celem bankowania komórek macierzystych jest ich późniejsze wykorzystanie w terapii. Krew pępowinowa została zastosowana po raz pierwszy w 1988 roku, a od tego czasu – zgodnie z dostępnymi danymi – komórki macierzyste zostały użyte na świecie ponad 85 000 razy (łącznie ze statystykami z Chin).

    Grupa FamiCord przechowuje ponad 1 000 000 porcji komórek różnych typów i dostarczyła komórki macierzyste do zastosowań klinicznych dla ponad 7000 pacjentów. Dostarczamy komórki do standardowych przeszczepień (z krwi pępowinowej, szpiku kostnego i mobilizowanej krwi obwodowej) oraz do terapii komórkowych. Ponadto wytwarzamy produkty komórkowe w standardzie GMP (ang. Good Manufacturing Practice) do badań klinicznych.

    Komórki macierzyste pochodzące z naszych laboratoriów były wykorzystywane w leczeniu pacjentów z chorobami i wskazaniami z różnych obszarów terapeutycznych – m.in. hematologii, neurologii, okulistyki, ortopedii i dermatologii.

    Sprawdź pełną listę pacjentów, którzy otrzymali terapię komórkami macierzystymi pochodzącymi z laboratoriów Grupy FamiCord.

    Data aktualizacji: 06.2026

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord

    Lista pacjentów, którzy otrzymali komórki macierzyste z laboratoriów Grupy FamiCord
    Lp. Źródło Typ źródła Wskazanie Obszar medycyny Rok podania Terapia Kraj Wiek odbiorcy
    2601 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 28
    2602 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 17
    2603 Apheresis Allogeneic Severe Combined Immunodeficiency Hematology 2023 Standard Therapy Poland 1
    2604 Apheresis Allogeneic Systemic Mastocytosis  Hematology 2023 Standard Therapy Poland 63
    2605 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 15
    2606 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 28
    2607 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 12
    2608 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 65
    2609 Apheresis Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 18
    2610 Apheresis Allogeneic T-Cell Lymphoma Hematology 2023 Standard Therapy Poland 65
    2611 Apheresis Allogeneic Thalassemia Major Hematology 2023 Standard Therapy Poland 2
    2612 Apheresis Allogeneic Treatment-Related Myelodysplastic Syndrome  Hematology 2023 Standard Therapy Poland 67
    2613 Apheresis Allogeneic Treatment-Related Myelodysplastic Syndrome  Hematology 2023 Standard Therapy Poland 64
    2614 Apheresis Allogeneic Wiskott-Aldrich Syndrome Hematology 2023 Standard Therapy Poland 2
    2615 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2022 Experimental Therapy Poland 15
    2616 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2022 Experimental Therapy Poland 6
    2617 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2022 Experimental Therapy Poland 12
    2618 Skeletal Muscle Allogeneic – Related Duchenne Muscular Dystrophy (DMD) Genetic disorder 2022 Experimental Therapy Poland 7
    2619 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease Hematology 2022 Experimental Therapy Poland 2
    2620 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia Hematology 2022 Experimental Therapy Poland 4
    2621 Cord Tissue Allogeneic – Unrelated Acute Graft Versus Host Disease; Acute Lymphoblastic Leukemia Hematology 2022 Experimental Therapy Poland 5
    2622 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 42
    2623 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 60
    2624 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 69
    2625 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 70
    2626 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 54
    2627 Cord Tissue Allogeneic – Unrelated Amyotrophic Lateral Sclerosis Neurology 2022 Experimental Therapy Poland 76
    2628 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2629 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 9
    2630 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 3
    2631 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2632 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2633 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2634 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 12
    2635 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2636 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 5
    2637 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 4
    2638 Cord Tissue Allogeneic – Related Autism Neurology 2022 Experimental Therapy Poland 7
    2639 Cord Tissue Allogeneic – Related Autism Neurology 2022 Experimental Therapy Romania 14
    2640 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 4
    2641 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 2
    2642 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2643 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2644 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 5
    2645 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2646 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2647 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 3
    2648 Cord Tissue Allogeneic – Related Autism Neurology 2022 Experimental Therapy Poland/Romania 6
    2649 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2650 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2651 Cord Tissue Allogeneic – Related Autism Neurology 2022 Experimental Therapy Poland/Romania 8
    2652 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 13
    2653 Cord Tissue Allogeneic – Related Autism Neurology 2022 Experimental Therapy Poland/Romania 10
    2654 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2655 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2656 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 12
    2657 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 10
    2658 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 6
    2659 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 5
    2660 Cord Tissue Allogeneic – Unrelated Autism Neurology 2022 Experimental Therapy Poland 7
    2661 Cord Tissue Allogeneic – Unrelated Bone Marrow Transplant Rejection Hematology 2022 Experimental Therapy Poland 2
    2662 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 8
    2663 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 2
    2664 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 12
    2665 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2666 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 2
    2667 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 2
    2668 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 7
    2669 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 5
    2670 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2671 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2672 Cord Tissue Allogeneic – Related Cerebral Palsy Neurology 2022 Experimental Therapy Romania 3
    2673 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2674 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2675 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 1
    2676 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 2
    2677 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 3
    2678 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 11
    2679 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 5
    2680 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 7
    2681 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 7
    2682 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2022 Experimental Therapy Poland 1
    2683 Cord Tissue Allogeneic – Unrelated Duchenne Muscular Dystrophy (Dmd) Neurology 2022 Experimental Therapy Poland 21
    2684 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2022 Experimental Therapy Poland 51
    2685 Cord Tissue Allogeneic – Unrelated Encephalopathy Neurology 2022 Experimental Therapy Poland 8
    2686 Cord Tissue Allogeneic – Unrelated Epidermolysis Bullosa Dermatology 2022 Experimental Therapy Poland 18
    2687 Cord Tissue Allogeneic – Unrelated Epilepsy Neurology 2022 Experimental Therapy Poland 6
    2688 Cord Tissue Allogeneic – Unrelated Epilepsy; Global Developmental Delay; Hypoxic Encephalopathy Neurology 2022 Experimental Therapy Poland 3
    2689 Cord Tissue Allogeneic – Unrelated Epileptic Encephalopathy Neurology 2022 Experimental Therapy Poland 2
    2690 Cord Tissue Allogeneic – Unrelated Global Developmental Delay Neurology 2022 Experimental Therapy Poland 10
    2691 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2022 Experimental Therapy Poland 56
    2692 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2022 Experimental Therapy Poland 38
    2693 Cord Tissue Allogeneic – Unrelated Gonarthrosis Orthopedy 2022 Experimental Therapy Poland 49
    2694 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2022 Experimental Therapy Poland 1
    2695 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2022 Experimental Therapy Poland 2
    2696 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2022 Experimental Therapy Poland 16
    2697 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2022 Experimental Therapy Poland 2
    2698 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2022 Experimental Therapy Poland 11
    2699 Cord Tissue Allogeneic – Unrelated Lack Of Expected Normal Physical Development Neurology 2022 Experimental Therapy Poland 4
    2700 Cord Tissue Allogeneic – Related Lack Of Expected Normal Physical Development Neurology 2022 Experimental Therapy Romania 3